$ACLS
AXCELIS TECHNOLOGIES INC Stock $acls

$acls Overview Financials Valuation SEC Filings Company Website

2010 Q4 Form 10-K Financial Statement

#000104746912001874 Filed on February 29, 2012

Income Statement

Concept	2010 Q4	2009	2008 Q4
Revenue	$93.40M	$133.0M	$42.00M
YoY Change	141.34%	-46.83%	-53.13%
Cost Of Revenue	$61.90M	$105.0M	$52.80M
YoY Change	125.91%	-44.05%	-8.81%
Gross Profit	$31.50M	$28.06M	-$10.90M
YoY Change	176.32%	-55.17%	-134.28%
Gross Profit Margin	33.73%	21.1%	-25.95%
Selling, General & Admin	$16.30M	$59.30M	$19.60M
YoY Change	21.64%	-32.31%	-11.71%
% of Gross Profit	51.75%	211.29%
Research & Development	$11.00M	$32.66M	$13.60M
YoY Change	42.86%	-48.4%	-24.02%
% of Gross Profit	34.92%	116.38%
Depreciation & Amortization	$1.680M	$7.436M	$6.290M
YoY Change	-9.19%	-68.45%	7.52%
% of Gross Profit	5.33%	26.5%
Operating Expenses	$27.30M	$97.50M	$33.90M
YoY Change	29.38%	-36.52%	-16.71%
Operating Profit	$4.200M	-$69.43M	-$44.80M
YoY Change	-143.3%	-23.7%	403.37%
Interest Expense	$0.00	$1.676M	-$4.100M
YoY Change		-119.05%	-341.18%
% of Operating Profit	0.0%
Other Income/Expense, Net	-$1.900M	-$7.169M	-$500.0K
YoY Change	533.33%	3484.5%	-28.57%
Pretax Income	$2.300M	-$76.60M	-$141.7M
YoY Change	-123.0%	-60.88%	1249.52%
Income Tax	-$2.100M	$865.0K	-$300.0K
% Of Pretax Income	-91.3%
Net Earnings	$4.300M	-$77.50M	-$141.4M
YoY Change	-143.0%	-60.6%	1233.96%
Net Earnings / Revenue	4.6%	-58.26%	-336.67%
Basic Earnings Per Share
Diluted Earnings Per Share	$156.9K	-$2.992M	-$5.481M
COMMON SHARES
Basic Shares Outstanding		103.6M shares
Diluted Shares Outstanding		103.6M shares

Balance Sheet

Concept	2010 Q4	2009	2008 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.70M	$45.00M	$37.70M
YoY Change	1.56%	19.36%	-55.07%
Cash & Equivalents	$45.74M	$45.00M	$37.69M
Short-Term Investments
Other Short-Term Assets	$15.30M	$14.90M	$25.90M
YoY Change	2.68%	-42.47%	-47.57%
Inventory	$109.7M	$114.6M	$150.1M
Prepaid Expenses
Receivables	$57.89M	$19.10M	$27.50M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$228.6M	$193.6M	$241.2M
YoY Change	18.09%	-19.73%	-36.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$38.59M	$40.90M	$44.40M
YoY Change	-5.64%	-7.88%	-34.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00	$156.7M
YoY Change		-100.0%	17.91%
Other Assets	$13.54M	$16.10M	$12.90M
YoY Change	-15.89%	24.81%	-65.32%
Total Long-Term Assets	$52.24M	$57.00M	$214.0M
YoY Change	-8.35%	-73.36%	-26.51%
TOTAL ASSETS
Total Short-Term Assets	$228.6M	$193.6M	$241.2M
Total Long-Term Assets	$52.24M	$57.00M	$214.0M
Total Assets	$280.9M	$250.6M	$455.2M
YoY Change	12.08%	-44.95%	-32.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$36.71M	$9.700M	$8.100M
YoY Change	278.44%	19.75%	-70.11%
Accrued Expenses	$10.60M	$9.300M	$15.80M
YoY Change	13.98%	-41.14%	-7.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$83.20M
YoY Change		-100.0%
Total Short-Term Liabilities	$68.13M	$29.80M	$130.0M
YoY Change	128.62%	-77.08%	38.3%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$4.759M	$4.400M	$5.800M
YoY Change	8.16%	-24.14%	-42.0%
Total Long-Term Liabilities	$4.759M	$4.400M	$5.800M
YoY Change	8.16%	-24.14%	-93.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$68.13M	$29.80M	$130.0M
Total Long-Term Liabilities	$4.759M	$4.400M	$5.800M
Total Liabilities	$72.89M	$34.20M	$135.8M
YoY Change	113.12%	-74.82%	-26.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$293.5M
YoY Change
Common Stock	$106.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.218M
YoY Change
Treasury Stock Shares	120.0K shares
Shareholders Equity	$205.6M	$216.4M	$319.4M
YoY Change
Total Liabilities & Shareholders Equity	$280.9M	$250.6M	$455.2M
YoY Change	12.08%	-44.95%	-32.05%

Cashflow Statement

Concept	2010 Q4	2009	2008 Q4
OPERATING ACTIVITIES
Net Income	$4.300M	-$77.50M	-$141.4M
YoY Change	-143.0%	-60.6%	1233.96%
Depreciation, Depletion And Amortization	$1.680M	$7.436M	$6.290M
YoY Change	-9.19%	-68.45%	7.52%
Cash From Operating Activities	-$7.480M	-$33.94M	-$14.59M
YoY Change	-292.78%	-30.34%	-535.52%
INVESTING ACTIVITIES
Capital Expenditures	-$640.0K	$463.0K	-$380.0K
YoY Change	700.0%	-113.58%	-80.71%
Acquisitions
YoY Change
Other Investing Activities	$3.640M	$123.8M	$6.270M
YoY Change	-2241.18%	1186.38%	-1841.67%
Cash From Investing Activities	$2.990M	$123.3M	$5.890M
YoY Change	-1296.0%	1882.15%	-352.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	810.0K	-83.12M	20.00K
YoY Change	406.25%	-9335.56%	-93.94%
NET CHANGE
Cash From Operating Activities	-7.480M	-33.94M	-14.59M
Cash From Investing Activities	2.990M	123.3M	5.890M
Cash From Financing Activities	810.0K	-83.12M	20.00K
Net Change In Cash	-3.680M	6.230M	-8.680M
YoY Change	-197.1%	-114.98%	-742.96%
FREE CASH FLOW
Cash From Operating Activities	-$7.480M	-$33.94M	-$14.59M
Capital Expenditures	-$640.0K	$463.0K	-$380.0K
Free Cash Flow	-$6.840M	-$34.40M	-$14.21M
YoY Change	-272.73%	-24.07%	-367.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2009	us-gaap	Royalty Revenue RoyaltyRevenue	389000	USD
CY2009	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	33917000	USD
CY2009	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	98716000	USD
CY2010	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104522000	shares
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104522000	shares
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17573000	USD
CY2009	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103586000	shares
CY2009	us-gaap	Interest Expense InterestExpense	1676000	USD
CY2009	us-gaap	Investment Income Interest InvestmentIncomeInterest	181000	USD
CY2009	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3238000	USD
CY2009	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	1080000	USD
CY2009	us-gaap	Operating Income Loss OperatingIncomeLoss	-69434000	USD
CY2009	us-gaap	Operating Expenses OperatingExpenses	97498000	USD
CY2009	us-gaap	Restructuring Charges RestructuringCharges	5541000	USD
CY2009	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34087000	USD
CY2009	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	25209000	USD
CY2009	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32661000	USD
CY2009	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103586000	shares
CY2009	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	104958000	USD
CY2009	us-gaap	Cost Of Services CostOfServices	20773000	USD
CY2009	us-gaap	Cost Of Goods Sold CostOfGoodsSold	84185000	USD
CY2009	us-gaap	Sales Revenue Net SalesRevenueNet	133022000	USD
CY2010	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	312000	USD
CY2010	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17261000	USD
CY2010	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3894000	USD
CY2010	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3990000	USD
CY2010	us-gaap	Investment Income Interest InvestmentIncomeInterest	96000	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-13367000	USD
CY2010	us-gaap	Operating Expenses OperatingExpenses	99205000	USD
CY2010	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32132000	USD
CY2010	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	27549000	USD
CY2010	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39524000	USD
CY2010	us-gaap	Gross Profit GrossProfit	85838000	USD
CY2010	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	189374000	USD
CY2010	us-gaap	Cost Of Services CostOfServices	21327000	USD
CY2010	us-gaap	Cost Of Goods Sold CostOfGoodsSold	168047000	USD
CY2010	us-gaap	Sales Revenue Net SalesRevenueNet	275212000	USD
CY2010	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	32441000	USD
CY2010	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	242771000	USD
CY2009	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-77468000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5077000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7471000	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	339000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	7132000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	107605000	USD
CY2011	us-gaap	Gross Profit GrossProfit	114737000	USD
CY2011	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	204679000	USD
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	319416000	USD
CY2009	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	865000	USD
CY2009	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-76603000	USD
CY2009	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7169000	USD
CY2009	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3516000	USD
CY2010Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2556000	USD
CY2010Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10597000	USD
CY2010Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	36709000	USD
CY2010Q4	us-gaap	Assets Assets	280872000	USD
CY2010Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13541000	USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	280872000	USD
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	68129000	USD
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2010Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4408000	USD
CY2010Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2010Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	105786000	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	106689000	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105906000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	106809000	shares
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2010Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2010Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13859000	USD
CY2010Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2010Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2010Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	120000	shares
CY2011Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	120000	shares
CY2010Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	107000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38594000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	205567000	USD
CY2010Q4	us-gaap	Assets Current AssetsCurrent	228630000	USD
CY2010Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15346000	USD
CY2010Q4	us-gaap	Inventory Net InventoryNet	109653000	USD
CY2010Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	57888000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45743000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	269245000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	214555000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	47472000	USD
CY2011Q4	us-gaap	Assets Assets	269245000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	212033000	USD
CY2010Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6232000	USD
CY2010Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-293520000	USD
CY2010Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1218000	USD
CY2010Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	493967000	USD
CY2010Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4759000	USD
CY2010Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2417000	USD
CY2009	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	734000	USD
CY2009	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	83344000	USD
CY2009	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	123285000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46877000	USD
CY2009	acls	Payments Related To Sale Of Equity Method Investments PaymentsRelatedToSaleOfEquityMethodInvestments	10590000	USD
CY2009	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	132847000	USD
CY2009	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1491000	USD
CY2009	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	463000	USD
CY2009	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-33942000	USD
CY2009	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4474000	USD
CY2009	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1154000	USD
CY2009	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-8695000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1403000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5892000	USD
CY2010	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2841000	USD
CY2010	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1406000	USD
CY2009	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	7326000	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	32276000	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3469000	USD
CY2010	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3549000	USD
CY2010	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38652000	USD
CY2010	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	10601000	USD
CY2010	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	553000	USD
CY2010	acls	Payments Of Financing Fees And Other Expenses PaymentsOfFinancingFeesAndOtherExpenses	523000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	5653000	USD
CY2010	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-7056000	USD
CY2009	us-gaap	Interest Paid InterestPaid	3009000	USD
CY2009	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11038000	USD
CY2009	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8131000	USD
CY2009	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-26445000	USD
CY2009	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8572000	USD
CY2009	us-gaap	Inventory Write Down InventoryWriteDown	9818000	USD
CY2009	us-gaap	Share Based Compensation ShareBasedCompensation	4651000	USD
CY2009	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-765000	USD
CY2009	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7436000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45020000	USD
CY2010	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2286000	USD
CY2010	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	723000	USD
CY2010	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	363000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	599000	USD
CY2008Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37694000	USD
CY2010	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	569000	USD
CY2010	us-gaap	Inventory Write Down InventoryWriteDown	2015000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	4088000	USD
CY2010	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1525000	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7045000	USD
CY2009	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	1098000	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	1134000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	591000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2121000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3533000	USD
CY2009	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-83115000	USD
CY2009	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	184000	USD
CY2009	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	45000	USD
CY2010	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-201000	USD
CY2010	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	638000	USD
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	553000	USD
CY2010	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16480000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4088000	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	216399000	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4651000	USD
CY2009	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-104000	USD
CY2009	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	184000	USD
CY2009	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	45000	USD
CY2009	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-107754000	USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	319377000	USD
CY2010Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	106000	USD

Files In Submission

Name	View Source	Status
0001047469-12-001874-index-headers.html	Edgar Link	pending
0001047469-12-001874-index.html	Edgar Link	pending
0001047469-12-001874.txt	Edgar Link	pending
0001047469-12-001874-xbrl.zip	Edgar Link	pending
a2207604z10-k.htm	Edgar Link	pending
a2207604zex-10_10.htm	Edgar Link	pending
a2207604zex-10_11.htm	Edgar Link	pending
a2207604zex-10_14.htm	Edgar Link	pending
a2207604zex-10_16.htm	Edgar Link	pending
a2207604zex-10_4.htm	Edgar Link	pending
a2207604zex-21_1.htm	Edgar Link	pending
a2207604zex-23_1.htm	Edgar Link	pending
a2207604zex-31_1.htm	Edgar Link	pending
a2207604zex-31_2.htm	Edgar Link	pending
a2207604zex-32_1.htm	Edgar Link	pending
a2207604zex-32_2.htm	Edgar Link	pending
acls-20111231.xml	Edgar Link	completed
acls-20111231.xsd	Edgar Link	pending
acls-20111231_cal.xml	Edgar Link	unprocessable
acls-20111231_def.xml	Edgar Link	unprocessable
acls-20111231_lab.xml	Edgar Link	unprocessable
acls-20111231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACLS
AXCELIS TECHNOLOGIES INC Stock $acls

2010 Q4 Form 10-K Financial Statement

#000104746912001874 Filed on February 29, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACLS AXCELIS TECHNOLOGIES INC Stock $acls

2010 Q4 Form 10-K Financial Statement

#000104746912001874 Filed on February 29, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACLS
AXCELIS TECHNOLOGIES INC Stock $acls